超卓航科(688237.SH):擬將超募資金1538.72萬元的節餘資金永久補充流動資金
格隆匯6月6日丨超卓航科(688237.SH)公佈,公司於2025年6月6日召開第三屆董事會第三十四次會議及第三屆監事會第二十六次會議,審議通過了《關於變更募投項目投資總額並結項並將節餘募集資金繼續存放於募集資金專戶的議案》及《關於將超募資金的節餘資金永久補充流動資金的議案》,董事會同意變更“增材製造生產基地項目”及“洛陽增材製造生產基地項目”的投資總額並進行結項,並將項目節餘募集資金繼續存放於募集資金專戶,同時同意將超募資金的節餘資金永久補充流動資金。
本次超募資金節餘資金1,538.72萬元系超募資金利息收入及現金管理累計收益扣除手續費等的淨額。爲進一步充盈公司現金流,提升經濟效益,公司擬將前述超募資金節餘資金1,538.72萬元(實際金額以資金轉出當日募集資金專戶餘額爲準)永久補充流動資金,用於公司及子公司日常生產經營活動。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.